Vuitton, Lucine

JAK inhibitors for the treatment of autoimmune and inflammatory diseases

Jamilloux, Y., El Jammal, T., Vuitton, L., Gerfaud-Valentin, M., Kerever, S., & Sève, P. (2019) · Autoimmunity Reviews

Cytokine Signaling Pathways and InteractionsRheumatoid Arthritis Research and Therapies

Cited by 264

Vedolizumab therapy is ineffective for primary sclerosing cholangitis in patients with inflammatory bowel disease: a GETAID multicentre cohort study

Caron, B., Peyrin-Biroulet, L., Pariente, B., Bouhnik, Y., Seksik, P., Bouguen, G., Caillo, L., Laharie, D., Carbonnel, F., Altwegg, R., et al. (2019) · Journal of Crohn's and Colitis

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 60

Evaluating the Risk of Irreversible Intestinal Necrosis Among Critically Ill Patients With Nonocclusive Mesenteric Ischemia

Calame, P., Winiszewski, H., Doussot, A., Malakhia, A., Grillet, F., Verdot, P., Vuitton, L., Ronot, M., Pili-Floury, S., Heyd, B., et al. (2021) · American Journal of Gastroenterology

Abdominal vascular conditions and treatmentsSepsis Diagnosis and Treatment

Cited by 34